Difference between revisions of "Team:Freiburg/Parts"

(Prototype team page)
 
 
(41 intermediate revisions by 9 users not shown)
Line 1: Line 1:
{{Freiburg}}
+
{{Freiburg/CSS}}
 +
{{Freiburg/Menubar}}
 +
 
 +
{{Team:Freiburg/wiki_content_start_bubble}}
 
<html>
 
<html>
 +
<style>
 +
/*========= BEGIN: style for navigation bar ==========*/
 +
#results {
 +
    background: url(https://static.igem.org/mediawiki/2015/2/2e/Freiburg_icon_results_active_yellow.png) no-repeat;
 +
}
  
<h2> Part Documentation</h2>
+
#results a {
 +
    color: #ecdc18;
 +
}
  
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
#runningchip {
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
    left: 52%;
 +
}
 +
/*========= END: style for navigation bar ==========*/
 +
</style>
  
 +
<script type="text/javascript">
 +
//===================BEGIN:Amazing Bubble Sidebar==========================
  
<div class="highlightBox">
+
$(document).ready(function(){
<h4>Note</h4>
+
  // CHANGE THE FOLLOWING ATTRIBUTES //
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
  var href_text1='https://2015.igem.org/Team:Freiburg/Results',
</div>
+
  // Text2 needs no href as it is the actual page //
 +
  img_url='https://static.igem.org/mediawiki/2015/1/1e/Freiburg_icon_results_white_03.png',
 +
  href_text3='https://2015.igem.org/Team:Freiburg/Collaborations',
 +
  // Text1 needs no text as it is a pic //
 +
  text2='BioBricks';
 +
  // Text3 needs no text as its always 'next' //
 +
  // HOLD ON CHANGING THINGS --JABBERWOCK  //
  
 +
  $('#bubble1').attr('href',href_text1);
 +
  $('#bubble1_img').attr('src', img_url);
 +
  $('#bubble3').attr('href',href_text3);
  
 +
  $('#bubble2').text(text2);
 +
});
  
<h4>Adding parts to the registry</h4>
+
//===================END:Amazing Bubble Sidebar==========================
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
</script>
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
  
 +
<div class="content_box">
 +
<!-- Labjournal content goes in here -->
 +
  
<h4>What information do I need to start putting my parts on the Registry?</h4>
+
<h1 class="sectionedit1">BioBricks</h1>
<p>The information needed to initially create a part on the Registry is:</p>
+
<div class="level1">
<ul>
+
<li>Part Name</li>
+
<li>Part type</li>
+
<li>Creator</li>
+
<li>Sequence</li>
+
<li>Short Description (60 characters on what the DNA does)</li>
+
<li>Long Description (Longer description of what the DNA does)</li>
+
<li>Design considerations</li>
+
</ul>
+
  
 +
<p>
 +
Our project involved the expression of many antigenic peptides. Their immunodominant properties make them feasible for many medical purposes. As ‘Health and Medicine’ is one of the most popular tracks chosen by iGEM Teams, we want to share the sequences encoding for these peptides with the iGEM Community. Thus, future iGEM Teams have the opportunity to take advantage of our research if they are planning to work in the field of diagnostics.
 +
<br>
 +
Most of the sequences were obtained by paper research and have been synthesized by <a class="media" href="https://eu.idtdna.com/site" target="_blank" title="IDT">Integrated DNA technologies</a>, engaging their special offer for iGEM Teams. Before ordering, we used the IDT codon optimization tool to optimize the sequences for efficient expression in <i>E. coli</i>. Planning to submit the sequences to the Registry, recognition sites for restriction enzymes used for standard cloning have been removed without causing amino acid changes.
 +
<br>
 +
The group of Prof. Dr. Stefan Dübel (TU Braunschweig) provided us with an <a href="http://parts.igem.org/Part:BBa_K1621006" target="_blank">antigen specific for <i>Salmonella</i> Typhimurium</a> and a corresponding single chain variable fragment (scFv). They generated the scFv themselves after identifying the immunodominant properties of the protein. Thanks to their work we are able to provide the Registry with a specific pair of antigen and scFv.
 +
<br>
 +
All our BioBricks are summarized in the table below. Additionally, the table guides you to more detailed info pages as well as to the corresponding Registry pages.
 
<p>
 
<p>
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
+
Although these parts significantly expand the <a class="media" href="http://parts.igem.org/Main_Page" target="_blank" title="Registry">Registry</a> in terms of diagnostics, none of them is our favorite BioBrick. To reach the high yields of protein expression we needed for our project we used a commercial vector optimized for inducible protein overexpression. This was unavoidable as inserting the required parts (like the lacI gene or a lacI repressible promoter) into pSB1C3 did not result in satisfying protein amounts. Most likely these problems were due to the high-copy origin of replication wasting a lot of metabolic capacity on unnecessary replication.<br>
 +
So far, the only plasmid backbone in the Registry with a low-copy origin of replication is <a class="urlextern" href="http://parts.igem.org/Part:pSB6A1" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:pSB6A1">pSB6A1</a>.
  
 +
<p>
 +
Therefore, we developed an improved version of this plasmid backbone by combining it with a commercial expression vector. Uniting features required for efficient protein overexpression and elements related to iGEM standard cloning, we enable future iGEM Teams to perform highly productive protein overexpression based on our new backbone.
 +
<br>
 +
Working <i>in vitro</i> is an upcoming issue in synthetic biology. The rapid development of chemical methods for gene or RNA synthesis are only examples emphasizing the importance of <i>in vitro</i> experiments. On the other side, the variety of methods for <i>in vitro</i> protein production is rather small<sup><a class="fn_top" href="#fn__1" id="fnt__1" name="fnt__1">1)</a></sup> making conventional protein expression and purification still an essential method. Therefore, pOP, the <strong>p</strong>lasmid for <strong>O</strong>verexpression of <strong>P</strong>roteins, is our favorite BioBrick.
 +
<p>
 +
Find out more about the <a href="https://2015.igem.org/Team:Freiburg/Description">pOP vector </a>and check if it also meets your requirements!
 +
</p>
  
 +
<div class="flexbox">
 +
<p>
 +
<a class="media" href="https://static.igem.org/mediawiki/2015/4/40/Freiburg_labjournal-cloning-biobricks.jpg" title="labjournal:cloning:biobricks.jpg"><img alt="" class="mediacenter" src="https://static.igem.org/mediawiki/2015/4/40/Freiburg_labjournal-cloning-biobricks.jpg" width="700"/></a>
 +
</p>
 +
</div>
 +
<div class="table sectionedit2"><table class="inline">
 +
<tr class="row0">
 +
<th class="col1 leftalign"> BioBrick  </th><th class="col1 leftalign"> short description  </th><th class="col0 centeralign"> detailed desription  </th>
 +
</tr>
 +
<tr class="row1">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621009" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621009">BBa_K1621009</a></td><td class="col0"> Standardized plasmid backbone optimized for protein overexpression</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Description" title="pop_-_protein_expression_meets_igem_standards">pOP</a></td>
 +
</tr>
 +
<tr class="row2">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621006" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621006">BBa_K1621006</a></td><td class="col0"><i> Salmonella</i> Typhimurium specific antigenic protein (DHAD)<td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_15" title="prig15_15">pRIG15_15</a></td>
 +
</tr>
 +
<tr class="row3">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621005" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621005">BBa_K1621005</a></td><td class="col0"> <i> Treponema pallidum</i> specific antigenic peptides derived from bacterioferritin (TpF1)</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_18" title="prig15_18">pRIG15_18</a></td>
 +
</tr>
 +
<tr class="row4">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621004" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621004">BBa_K1621004</a></td><td class="col0"> Human Immunodeficiency Virus specific antigenic epitopes derived from a polyprotein called gag/tat/pol/env</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_17" title="prig15_17">pRIG15_17</a></td>
 +
</tr>
 +
<tr class="row5">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621003" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621003">BBa_K1621003</a></td><td class="col0"> <i> Clostridium tetani</i> specific antigenic epitopes derived from tetanus neurotoxin (TeNT_Hc)</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_11" title="prig15_11">pRIG15_11</a></td>
 +
</tr>
 +
<tr class="row6">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621002" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621002">BBA_K1621002</a></td><td class="col0"> Herpes Simplex specific antigenic epitopes derived from glycoprotein G</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_8" title="prig15_8">pRIG15_8</a></td>
 +
</tr>
 +
<tr class="row7">
 +
<td class="col1"><a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621001" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621001">BBa_K1621001</a></td><td class="col0"> Varicella Zoster Virus specific antigenic epitopes derived from glycoprotein E</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_7" title="prig15_7">pRIG15_7</a></td>
 +
</tr>
 +
<tr class="row8">
 +
<td class="col1"> <a class="urlextern" href="http://parts.igem.org/Part:BBa_K1621000" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621000">BBa_K1621000</a></td><td class="col0"> Rubella Virus specific antigenic epitopes derived from glycoprotein E1</td><td class="col0"><a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_6" title="pRIG15_6">pRIG15_6</a></td>
 +
</tr>
  
  
  
  
<h4>Inspiration</h4>
 
<p>We have a created  a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
 
  
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
 
<ul>
 
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
 
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
 
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
 
</ul>
 
  
 +
</table></div>
  
 
+
<div class="footnotes">
<h4>Part Table </h4>
+
<div class="fn"><sup><a class="fn_bot" href="#fnt__1" id="fn__1" name="fn__1">1)</a></sup>
</html>
+
<a class="urlextern" href="http://genome.cshlp.org/content/17/1/1.full" rel="nofollow" target="_Blank" title="http://genome.cshlp.org/content/17/1/1.full">Forster and Church, 2015. Genome Research.</a></div>
<groupparts>iGEM015 Example</groupparts>
+
<html>
+
 
+
  
  
 
</div>
 
</div>
 
</html>
 
</html>
 +
<!-- Labjournal content ends here -->
 +
{{Freiburg/wiki_content_end}}

Latest revision as of 02:01, 19 September 2015

""

BioBricks

Our project involved the expression of many antigenic peptides. Their immunodominant properties make them feasible for many medical purposes. As ‘Health and Medicine’ is one of the most popular tracks chosen by iGEM Teams, we want to share the sequences encoding for these peptides with the iGEM Community. Thus, future iGEM Teams have the opportunity to take advantage of our research if they are planning to work in the field of diagnostics.
Most of the sequences were obtained by paper research and have been synthesized by Integrated DNA technologies, engaging their special offer for iGEM Teams. Before ordering, we used the IDT codon optimization tool to optimize the sequences for efficient expression in E. coli. Planning to submit the sequences to the Registry, recognition sites for restriction enzymes used for standard cloning have been removed without causing amino acid changes.
The group of Prof. Dr. Stefan Dübel (TU Braunschweig) provided us with an antigen specific for Salmonella Typhimurium and a corresponding single chain variable fragment (scFv). They generated the scFv themselves after identifying the immunodominant properties of the protein. Thanks to their work we are able to provide the Registry with a specific pair of antigen and scFv.
All our BioBricks are summarized in the table below. Additionally, the table guides you to more detailed info pages as well as to the corresponding Registry pages.

Although these parts significantly expand the Registry in terms of diagnostics, none of them is our favorite BioBrick. To reach the high yields of protein expression we needed for our project we used a commercial vector optimized for inducible protein overexpression. This was unavoidable as inserting the required parts (like the lacI gene or a lacI repressible promoter) into pSB1C3 did not result in satisfying protein amounts. Most likely these problems were due to the high-copy origin of replication wasting a lot of metabolic capacity on unnecessary replication.
So far, the only plasmid backbone in the Registry with a low-copy origin of replication is pSB6A1.

Therefore, we developed an improved version of this plasmid backbone by combining it with a commercial expression vector. Uniting features required for efficient protein overexpression and elements related to iGEM standard cloning, we enable future iGEM Teams to perform highly productive protein overexpression based on our new backbone.
Working in vitro is an upcoming issue in synthetic biology. The rapid development of chemical methods for gene or RNA synthesis are only examples emphasizing the importance of in vitro experiments. On the other side, the variety of methods for in vitro protein production is rather small1) making conventional protein expression and purification still an essential method. Therefore, pOP, the plasmid for Overexpression of Proteins, is our favorite BioBrick.

Find out more about the pOP vector and check if it also meets your requirements!

BioBrick short description detailed desription
BBa_K1621009 Standardized plasmid backbone optimized for protein overexpressionpOP
BBa_K1621006 Salmonella Typhimurium specific antigenic protein (DHAD)pRIG15_15
BBa_K1621005 Treponema pallidum specific antigenic peptides derived from bacterioferritin (TpF1)pRIG15_18
BBa_K1621004 Human Immunodeficiency Virus specific antigenic epitopes derived from a polyprotein called gag/tat/pol/envpRIG15_17
BBa_K1621003 Clostridium tetani specific antigenic epitopes derived from tetanus neurotoxin (TeNT_Hc)pRIG15_11
BBA_K1621002 Herpes Simplex specific antigenic epitopes derived from glycoprotein GpRIG15_8
BBa_K1621001 Varicella Zoster Virus specific antigenic epitopes derived from glycoprotein EpRIG15_7
BBa_K1621000 Rubella Virus specific antigenic epitopes derived from glycoprotein E1pRIG15_6